Outcome of toxic dilatation in ulcerative and Crohn's colitis.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 4008909)

Published in J Clin Gastroenterol on April 01, 1985

Authors

A J Greenstein, D B Sachar, A Gibas, D Schrag, T Heimann, H D Janowitz, A H Aufses

Articles by these authors

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90

Intussusception in adults: institutional review. J Am Coll Surg (1999) 5.05

The influence of hospital volume on survival after resection for lung cancer. N Engl J Med (2001) 4.83

The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med (1990) 4.53

Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01

Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59

Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51

Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48

The superior mesenteric artery syndrome. The disease that isn't, or is it? J Clin Gastroenterol (1985) 2.13

A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83

How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75

Lifestyle prescriptions for cancer survivors and their communities. J Intern Med (2010) 1.68

Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med (1998) 1.67

Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59

A prospective, randomized trial of short versus long tubes in adhesive small-bowel obstruction. Am J Surg (1995) 1.56

Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53

Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52

Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51

Age and sex distribution of patients with colorectal cancer. Dis Colon Rectum (1989) 1.51

Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol (2009) 1.49

Cholesterol and obesity as prognostic factors in breast cancer. Cancer (1981) 1.47

Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45

Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44

Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43

Perpetuation of published medical errors. Lancet (1993) 1.43

Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43

Granulomatous ileocolitis. Gut (1966) 1.42

Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut (1983) 1.42

Continuing changing patterns of disease in pyogenic liver abscess: a study of 38 patients. Am J Gastroenterol (1984) 1.40

Sera-reactivity in inflammatory bowel disease: frequency of recognition of Crohn's disease tissue primed nude mouse lymphoid tissue in an interinstitutional blinded study. J Clin Gastroenterol (1989) 1.40

ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen. J Clin Gastroenterol (1990) 1.40

Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38

Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36

Carcinoma developing in ileostomies after 25 or more years. Gastroenterology (1988) 1.34

Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34

Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33

Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg (1997) 1.32

A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am J Gastroenterol (1983) 1.32

Parity and prognosis in breast cancer. Cancer (1980) 1.28

Intestinal transmural electric potential and its response to glucose in acute and convalescent cholera. Gastroenterology (1969) 1.27

Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27

Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26

Ovarian carcinomatosis presenting with hyperamylasemia and pleural effusion. Am J Gastroenterol (1981) 1.24

Free perforation in Crohn's disease: I. A survey of 99 cases. Am J Gastroenterol (1985) 1.23

Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22

Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut (1981) 1.22

Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet (1991) 1.22

Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol (1997) 1.21

Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20

Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol (2000) 1.19

The role of the fecal stream in Crohn's disease: an historical and analytic review. Inflamm Bowel Dis (1998) 1.19

Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18

Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18

Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol (2007) 1.18

Early complications following surgical treatment for Crohn's disease. Ann Surg (1985) 1.18

Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol (2011) 1.17

Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17

The surgery of Crohn's disease. Surg Clin North Am (1987) 1.17

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma. Ann Oncol (2011) 1.16

Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16

Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16

Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut (1991) 1.15

Ileostomy for granulomatous ileocolitis. Ann Surg (1971) 1.13

Benign and malignant colorectal strictures in ulcerative colitis. Gut (1992) 1.13